$1.2M Grant Awarded for Groundbreaking Prostate Cancer Research on SynDevRx MetAP2 Inhibitor 'Evexomostat'
Award follows extensive pre-clinical, single agent activity data generated by Prof. Colleen Nelson’s lab at QUT in ‘Aggressive Variant’ prostate cancer models CAMBRIDGE, MA, UNITED STATES, January 9, 2025 /EINPresswire.com/ -- Cambridge, MA (USA …